首页> 美国卫生研究院文献>American Journal of Translational Research >Cathepsin D protects renal tubular cells from damage induced by high glucose independent of its enzymatic activity
【2h】

Cathepsin D protects renal tubular cells from damage induced by high glucose independent of its enzymatic activity

机译:组织蛋白酶D保护肾小管细胞免受高葡萄糖诱导的损伤而不受其酶促活性的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although glomerular and vascular damage have been considered the main characteristics of diabetic kidney disease (DKD), accumulating data now indicate that tubular atrophy also plays a major role. Cathepsin D (CatD) is the major aspartate protease within lysosomes. The current study demonstrated that CatD expression was altered in the renal tubular epithelium in patients with diabetes mellitus (DM). In contrast to its low and uniform distribution in the tubular epithelium in normal kidney tissues, CatD demonstrated flecked and increased expression in tubules with relatively integral structures, and disappeared in disordered tubules in DM kidney tissues. In vitro studies demonstrated that CatD protected HK2 cells from the damage induced by high glucose and advanced glycation end-products (AGEs), independent of its enzymatic activity. In addition, the current study demonstrated that AGEs induced lysosome membrane permeabilization (LMP) and loss of mitochondrial membrane potential (MMP). Overexpression of CatD prevented LMP and maintained the MMP in HK2 cells exposed to AGEs. In addition, the catalytic activity of CatD was not required for its role in LMP prevention and MMP maintenance. These results indicate, for the first time that CatD may improve the viability of renal tubular cells in the presence of diabetic mediators independent of its enzymatic activity by preventing LMP and stabilizing the MMP.
机译:尽管肾小球和血管损伤已被认为是糖尿病肾病(DKD)的主要特征,但目前的累积数据表明肾小管萎缩也起着重要作用。组织蛋白酶D(CatD)是溶酶体内的主要天冬氨酸蛋白酶。目前的研究表明,糖尿病(DM)患者的肾小管上皮细胞CatD表达发生了改变。与正常肾脏组织中肾小管上皮的低而均匀的分布相反,CatD在具有相对完整结构的肾小管中表现出斑点和增加的表达,而在DM肾组织中无序的肾小管中消失。体外研究表明,CatD保护HK2细胞免受高葡萄糖和高级糖基化终产物(AGEs)诱导的损害,而不受其酶促活性的影响。此外,当前的研究表明AGEs诱导了溶酶体膜通透性(LMP)和线粒体膜电位(MMP)的损失。 CatD的过度表达可防止LMP并维持暴露于AGEs的HK2细胞中的MMP。此外,CatD在LMP预防和MMP维持中的作用不需要催化活性。这些结果首次表明,通过预防LMP和稳定MMP,CatD可以在存在糖尿病介质的情况下改善肾小管细胞的生存能力,而不受其酶促活性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号